Article
BRAF-targeting combination beats chemotherapy in pediatric glioma
Rating:
0.0
Views:
47
Likes:
1
Library:
1
First-line treatment with dabrafenib plus trametinib resulted in better clinical responses and lower toxicity than chemotherapy in children with BRAF V600E mutation and low-grade glioma.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value